| Bioactivity | STAT3-IN-41 (Compound 16) is a prodrug of compound 1. STAT3-IN-41 slowly releases compound 1 inhibiting STAT3 signaling pathway. STAT3-IN-41 shows antitumor activity against lung cancer, hepatocellular carcinoma and pancreatic cancer[1]. |
| Formula | C22H30F3NO7 |
| Molar Mass | 477.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Duan X, et al. Discovery of novel fluorine-containing parthenolide analogues as potential antitumor agents. Eur J Med Chem. 2025 Mar 15;286:117283. |